Jie Jin

18.8k total citations · 1 hit paper
593 papers, 8.5k citations indexed

About

Jie Jin is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Jie Jin has authored 593 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 249 papers in Hematology, 206 papers in Molecular Biology and 124 papers in Genetics. Recurrent topics in Jie Jin's work include Acute Myeloid Leukemia Research (165 papers), Chronic Lymphocytic Leukemia Research (65 papers) and Lymphoma Diagnosis and Treatment (65 papers). Jie Jin is often cited by papers focused on Acute Myeloid Leukemia Research (165 papers), Chronic Lymphocytic Leukemia Research (65 papers) and Lymphoma Diagnosis and Treatment (65 papers). Jie Jin collaborates with scholars based in China, United States and Japan. Jie Jin's co-authors include Wenbin Qian, Yungui Wang, Hongyan Tong, Yinjun Lou, Haitao Meng, Hong‐Hu Zhu, Jiansong Huang, Huafeng Wang, Weilai Xu and Jianjun Chen and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Jie Jin

547 papers receiving 8.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Platelet integrin αIIbβ3: signal transduction, regulation, and its therapeutic targeting

2019 269 citations Jiansong Huang, Huafeng Wang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jie Jin China	43	4.0k	2.4k	1.5k	1.3k	1.2k	593	8.5k
He Huang China	50	4.3k 1.1×	2.3k 1.0×	3.0k 2.0×	850 0.6×	938 0.8×	576	10.5k
Giorgina Specchia Italy	48	2.8k 0.7×	4.1k 1.7×	2.0k 1.3×	580 0.4×	2.3k 2.0×	401	10.4k
Ardeshir Ghavamzadeh Iran	36	2.3k 0.6×	2.0k 0.8×	1.0k 0.7×	605 0.5×	2.0k 1.7×	363	6.5k
Alfonso Quintás‐Cardama United States	53	4.0k 1.0×	5.5k 2.3×	1.7k 1.2×	648 0.5×	4.4k 3.8×	407	11.6k
Vicente Vicente Spain	53	2.1k 0.5×	4.5k 1.8×	851 0.6×	945 0.7×	1.2k 1.0×	497	11.4k
Johann Wojta Austria	56	3.4k 0.8×	1.4k 0.6×	1.1k 0.7×	1.9k 1.4×	563 0.5×	436	12.8k
Jane E. Freedman United States	54	3.3k 0.8×	1.6k 0.6×	664 0.5×	1.7k 1.2×	286 0.2×	175	10.2k
Adrian C. Newland United Kingdom	51	1.8k 0.4×	3.9k 1.6×	1.2k 0.8×	321 0.2×	1.2k 1.0×	281	8.1k
Roman Hájek Czechia	50	6.5k 1.6×	6.9k 2.8×	5.1k 3.5×	704 0.5×	1.1k 1.0×	567	10.9k
Xiaoli Zhang United States	41	3.6k 0.9×	459 0.2×	1.5k 1.0×	1.8k 1.3×	1.1k 0.9×	200	7.0k

Countries citing papers authored by Jie Jin

Since Specialization

Citations

This map shows the geographic impact of Jie Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Jin more than expected).

Fields of papers citing papers by Jie Jin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Jin. The network helps show where Jie Jin may publish in the future.

Co-authorship network of co-authors of Jie Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Jie Jin. A scholar is included among the top collaborators of Jie Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Jin. Jie Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zheng, Qiang, Jinglin Zhao, Yimiao He, et al.. (2025). Glutamate boosts IMP production in triploid crucian carp muscle via phosphoribosyl pyrophosphate amido transferase and ATP pathways. Aquaculture. 603. 742346–742346. 1 indexed citations

Jin, Jie, Kun Cheng, Mingrui Chen, Huifang Liang, & Wanguang Zhang. (2025). Immunotherapy resistance in MASLD-related hepatocellular carcinoma: special immune microenvironment and gut microbiota. International Journal of Biological Sciences. 21(13). 5666–5690.

Chen, Dechao, et al.. (2025). VSDRL: A robust and accurate unmanned aerial vehicle autonomous landing scheme. IET Control Theory and Applications. 19(1).

Jiang, Xia, Youhong Li, Fenglin Li, et al.. (2024). NL101 synergizes with the BCL-2 inhibitor venetoclax through PI3K-dependent suppression of c-Myc in acute myeloid leukaemia. Journal of Translational Medicine. 22(1). 867–867. 2 indexed citations

Wang, Huafeng, Xudong Wei, Yang Liang, et al.. (2024). Lisaftoclax (APG-2575), a Novel BCL-2 Inhibitor, in Combination with Azacitidine in Treatment of Patients with Myelodysplastic Syndrome (MDS). Blood. 144(Supplement 1). 3202–3202.

Jin, Jie, et al.. (2024). Variable and Invariable, Explore the Value-Creation Techniques of Management Accounting by Benchmarking the Financial Management of Large Enterprises. Proceedings of Business and Economic Studies. 7(1). 45–50.

Jin, Jie, Miao Liu, Liping Mao, et al.. (2023). Phosphoproteomic Characterization and Kinase Signature Predict Response to Venetoclax Plus 3+7 Chemotherapy in Acute Myeloid Leukemia. Advanced Science. 11(11). e2305885–e2305885. 3 indexed citations

Zhang, Yi, Jie Chang, Huafeng Wang, et al.. (2023). CAG (cytarabine, aclarubicin and granulocyte colony-stimulating factor) regimen for core binding factor acute myeloid leukaemia with measurable residual disease. Annals of Hematology. 102(7). 1731–1738. 1 indexed citations

Zhang, Yi, et al.. (2023). Solitons and dynamics for the shifted reverse space–time complex modified Korteweg–de Vries equation. Nonlinear Dynamics. 111(19). 18363–18371. 3 indexed citations

10.

Ye, Wenle, Xin Huang, Jiansong Huang, et al.. (2023). Glutamate dehydrogenase 1: A novel metabolic target in inhibiting acute myeloid leukaemia progression. British Journal of Haematology. 202(3). 566–577. 10 indexed citations

11.

Zhang, Yi, Wenwen Wei, Bin Zhang, et al.. (2023). STI-8591, a Novel Tyrosine Kinase Inhibitor, Shows Excellent Antileukemic Activity in FLT3-Mutated (mut) Acute Myeloid Leukemia (AML). Blood. 142(Supplement 1). 5010–5010.

12.

Yu, Lifei, Panpan Cen, Jiexia Ding, et al.. (2023). Neutrophil CD64 index as a good biomarker for early diagnosis of bacterial infection in pregnant women during the flu season. Influenza and Other Respiratory Viruses. 17(8). e13191–e13191. 1 indexed citations

13.

Lin, Xiangjie, et al.. (2022). The global burden and attributable risk factors of chronic lymphocytic leukemia in 204 countries and territories from 1990 to 2019: analysis based on the global burden of disease study 2019. BioMedical Engineering OnLine. 21(1). 45 indexed citations

14.

Song, Yuqin, Keshu Zhou, Dehui Zou, et al.. (2020). Treatment of Patients with Relapsed or Refractory Mantle–Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase. Clinical Cancer Research. 26(16). 4216–4224. 111 indexed citations

15.

Tan, Yao, S.L. Wang, Xin Zheng, et al.. (2019). Efficacy and Prognosis of Radiotherapy for Hepatocellular Carcinoma with Tumor Thrombosis in Main Portal Vein or/and Vena Cava. International Journal of Radiation Oncology*Biology*Physics. 105(1). E215–E216. 2 indexed citations

16.

Li, Zejuan, Ping Chen, Rui Su, et al.. (2016). PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL -Rearranged Disease. Cancer Research. 76(3). 619–629. 48 indexed citations

17.

Lin, Dandan, Man Zhang, Meng‐Xin Zhang, et al.. (2015). Induction of USP25 by viral infection promotes innate antiviral responses by mediating the stabilization of TRAF3 and TRAF6. Proceedings of the National Academy of Sciences. 112(36). 11324–11329. 107 indexed citations

18.

Zhu, Hong‐Hu, Depei Wu, Jie Jin, et al.. (2013). Oral Tetra-Arsenic Tetra-Sulfide Formula Versus Intravenous Arsenic Trioxide As First-Line Treatment of Acute Promyelocytic Leukemia: A Multicenter Randomized Controlled Trial. Journal of Clinical Oncology. 31(33). 4215–4221. 129 indexed citations

19.

Jin, Jie, Hui Liu, Chunmei Yang, et al.. (2009). Effective gene-viral therapy of leukemia by a new fiber chimeric oncolytic adenovirus expressing TRAIL: in vitro and in vivo evaluation. Molecular Cancer Therapeutics. 8(5). 1387–1397. 20 indexed citations

20.

Zhang, Zuofa, Jie Jin, & Liangen Shi. (2008). Antioxidant Activity of the Derivatives of Polysaccharide Extracted from a Chinese Medical Herb (Ramulus mori). Food Science and Technology Research. 14(2). 160–168. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact